NSLYF Financial Statements & Analysis
Complete financial statements for NSLYF including income statement, balance sheet, and cash flow statement. Analyze NSLYF's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
10.3% ↑
Net Income
23.2% ↑
Gross Margin
0.2% ↑
Operating Margin
13.0% ↑
Balance Sheet
Current Ratio
-4.8% ↓
Debt to Equity
-20.7% ↑
Asset Turnover
10.6% ↑
Cash Flow
Operating Cash Flow
74.2% ↑
Net Cash Flow
98.3% ↑
Free Cash Flow
214.2% ↑
Cash Flow to Debt
109.1% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 6.22B | 6.87B | 10.3% | |
| Gross Profit | 1.88B | 2.08B | 10.6% | |
| Operating Income | 609.00M | 759.10M | 24.6% | |
| Net Income | 415.62M | 511.89M | 23.2% | |
| EPS | 1.77 | 2.19 | 23.7% | |
| EBITDA | 829.90M | 985.48M | 18.7% | |
| Gross Margin | 30.28% | 30.35% | 0.2% | |
| Operating Margin | 9.78% | 11.06% | 13.0% | |
| Net Income Margin | 6.68% | 7.46% | 11.7% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 6.87B | 6.22B | 7.05B | — | — |
| Gross Profit | 2.08B | 1.88B | 2.23B | — | — |
| Operating Income | 759.10M | 609.00M | 939.34M | — | — |
| Net Income | 511.89M | 415.62M | 659.87M | — | — |
| EPS | 2.19 | 1.77 | 2.81 | — | — |
| EBITDA | 985.48M | 829.90M | 1.12B | — | — |
| Gross Margin | 30.35% | 30.28% | 31.64% | — | — |
| Operating Margin | 11.06% | 9.78% | 13.32% | — | — |
| Net Income Margin | 7.46% | 6.68% | 9.36% | — | — |
| R&D Expenses | 0 | 0 | 1.16M | — | — |
Financial Metrics
Want to dive deeper into NSLYF's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics